Innate Pharma S.A. Sponsored ADR IPHA

1.70 0.00 0.00% as of 25 Sep
Market cap
$188.8M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
38.82 87.40 100.07 106.92 141.78 173.22 245.13 197.85 139.89 208.09
Receivables
14.03 5.38 60.13 40.40 21.79 24.92 20.99 179.64 18.17 26.90
Inventory
— — — — — — — — — 0.54
Other current assets
— — — — — — — — 7.62 6.66
Total current assets
52.85 92.78 160.19 147.33 163.57 198.13 266.12 377.50 165.69 242.19
Property, Plant, Equpment (Net)
4.93 5.55 6.84 9.00 12.04 13.36 13.07 12.07 12.93 9.57
Long-Term Investments
11.83 11.13 10.60 37.00 47.18 44.47 41.45 41.55 70.39 33.10
Long-term receivables
0.28 10.09 11.42 14.85 35.28 34.06 18.75 — — —
Goodwill and Intangible Assets (Total)
— — 0.45 1.64 52.28 52.88 108.60 99.83 55.65 9.55
Long Term Assets (Tax, Deferred)
— — 9.75 9.03 5.95 8.10 1.44 1.84 — —
Long-term assets (Other)
1.07 0.62 0.09 0.16 0.18 0.17 0.10 0.10 2.60 1.99
Total non-current assets
18.11 27.40 39.16 71.68 152.91 153.04 183.41 155.39 — —
Total Assets
70.96 120.18 199.35 219.00 316.47 351.17 449.52 532.89 0.00 296.40
Accounts Payable
17.02 17.32 18.42 22.03 33.80 33.74 55.44 108.24 24.06 16.42
Current Part of Debt
9.96 9.42 9.67 2.21 36.38 2.45 2.39 1.59 1.17 0.94
Current Revenue (Deferred)
3.20 0.67 6.35 6.91 14.79 12.91 54.62 96.96 — —
Other current liabilities
11.29 8.28 8.46 12.40 9.54 2.86 23.99 25.56 63.82 63.11
Total current liabilities
41.46 35.69 42.90 43.55 94.51 51.96 136.44 232.35 89.05 80.46
Long Term Debt (Total)
15.58 24.12 33.50 42.30 15.98 19.36 18.58 3.75 4.55 3.17
Non-current Revenue (Deferred)
— 3.06 5.00 8.35 30.07 37.32 45.18 80.42 104.83 —
Pension and Post-Retirement Liabilities
2.18 2.95 2.64 2.69 3.52 4.77 4.21 4.37 — —
Long Term Tax Liability (Deferred)
— — 9.75 9.03 5.95 8.10 1.44 1.84 — —
Non-current Liabilities (Other)
36.30 44.80 49.39 56.04 39.34 51.49 0.16 12.65 5.28 122.06
Total non-current liabilities
54.05 74.93 100.28 118.40 94.85 121.04 69.58 103.03 — —
Total liabilities
95.52 110.62 143.18 161.95 189.36 173.00 206.02 335.38 203.70 205.69
Additional Paid In Capital
461.65 423.08 415.88 399.99 443.92 425.09 413.97 354.22 — —
Common Stock (Net)
5.30 4.54 4.38 4.23 4.71 4.51 4.41 3.78 3.47 2.84
Retained Earnings
(492.77) (418.08) (364.62) (348.02) (322.06) (251.83) (174.35) (159.19) (183.11) (109.05)
Shareholders Equity (Other)
1.26 0.03 0.54 0.86 0.54 0.41 (0.53) (1.30) — —
Common Equity (Total)
(24.56) 9.56 56.17 57.05 127.11 178.17 243.50 197.51 103.56 90.70
Shareholders Equity (Total)
(24.56) 9.56 56.17 57.05 127.11 178.17 243.51 197.51 103.56 90.70
Shareholders Equity and Liabilities (Total)
70.96 120.18 199.35 219.00 316.47 351.17 449.52 532.89 — —
Shares (Common)
93.72 83.84 80.45 79.54 79.56 79.00 78.83 64.04 — —
Shareholders Equity (Tangible)
(24.56) 9.56 55.72 55.41 74.83 125.30 134.90 97.68 — —
Net Debt
(13.28) (53.86) (56.89) (62.41) (89.42) (151.41) (224.16) (192.51) (134.18) (203.99)
Total Debt
25.54 33.54 43.18 44.52 52.35 21.80 20.97 5.34 5.71 4.11

Fold the line items

In millions of $ except per-share values · columns are period end dates